Municipal Public Health Services once again conduct more STI consultations than before COVID-19 The number of STI consultations at the Sexual Health Centres of the Municipal Public Health Services (GGDs) was 19% higher in 2022 compared to 2021.
More than two million invitations to get vaccinated against HPV in 2023 In early 2023, 1.3 million young adults will receive an invitation to get vaccinated against the human papillomavirus (HPV). This group comprises around 900,000 men and 400,000 women between the ages of 19 and 27.
Higher alert level for Ebola There is an Ebola outbreak in several regions of Uganda that are also frequented by tourists. RIVM therefore asks medical professionals to be alert to symptoms that could indicate Ebola among people who have travelled to Uganda, and to request diagnostics to rule out or confirm Ebola.
Nationwide study into chlamydia and gonorrhoea Today, the National Institute for Public Health and the Environment (RIVM) launches a nationwide study into chlamydia and gonorrhoea.
Hypersensitivity reactions to fillers may occur after COVID-19 vaccination People may experience hypersensitivity reactions to fillers following a COVID-19 vaccination.
Number of STI tests at sexual health centres are rising again In 2021, more than 138,000 people were tested for sexually transmitted infections (STIs) at a centre for sexual health.
Chromium-6 from medical implants not harmful to health Chromium-6 from medical implants, such as hip or knee implants, does not result in severe health damage.
More STI tests conducted by Sexual Health Centres In 2021, more people visited a Sexual Health Centre (SHC) to get tested for sexually transmitted infections (STIs) than in 2020. This figure is still lower than in 2019, the year before the coronavirus outbreak.
Most reports received by MEBI in 2021 concerned copper IUDs More reports of suspected adverse effects from copper intrauterine devices (IUDs) were made in 2021 than in previous years, according to the annual report of the Dutch reporting and expertise centre for adverse effects of medical implants (MEBI).
Shortcomings in the technical documentation of mesh implants intended to treat pelvic organ prolapse used in the Netherlands After a detailed assessment of the technical documentation of 9 different mesh implants intended to treat pelvic organ prolapse used in NL (2018) RIVM concludes that the safety and performance of these products were not properly substantiated.